Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]

Detlef Dieckmann, Cord Henrik Bruett, Heidi Ploettner, Manfred Bernhard Lutz, Gerold Schuler, Detlef Dieckmann, Cord Henrik Bruett, Heidi Ploettner, Manfred Bernhard Lutz, Gerold Schuler

Abstract

It has been recently demonstrated that regulatory CD4(+)CD25(+) CD45RO(+) T cells are present in the peripheral blood of healthy adults and exert regulatory function similar to their rodent counterparts. It remains difficult to understand how the small fraction of these T cells that regulate via direct cell-to-cell contact and not via secretion of immunosuppressive cytokines could mediate strong immune suppression. Here we show that human CD4(+)CD25(+) T cells induce long-lasting anergy and production of interleukin (IL)-10 in CD4(+)CD25(-) T cells. These anergized CD4(+)CD25(-) T cells then suppress proliferation of syngenic CD4(+) T cells via IL-10 but independent of direct cell contact, similar to the so-called type 1 regulatory T (Tr1) cells. This 'catalytic' function of CD4(+)CD25(+) T cells to induce Tr1-like cells helps to explain their central role for the maintenance of immune homeostasis.

Figures

Figure 1.
Figure 1.
Coculture of CD4+CD25+ and CD4+CD25− T cells results in high level IL-10 production. CD4+CD25+ and CD4+CD25− T cells were MACS® sorted from PBMCs of healthy individuals. These cells were either cultured alone or at a 1:1 ratio and activated with platebound anti-CD3 and soluble anti-CD28 (10 μg/ml, respectively). (A) After various time points supernatants were analyzed for cytokine production by ELISA. IL-10 production peaked 48 h after onset of culture and was markedly higher in the coculture of CD4+CD25+ and CD4+CD25− T cells than in the cultures of each of the cell types alone. A representative out of five independent standardized experiments is shown. No elevated levels of INF-α or TGF-β could be measured (data not shown). (B) The different T cell populations were also activated with mature allogeneic DCs (DC/T cell ratio 1:20) compared with anti-CD3 and anti-CD28 (10 μg/ml, respectively). Cytokines were measured 48 h after onset of culture. Results were similar in five independent experiments. (C) For the last 6 h of activation with anti-CD3 and anti-CD28 2 μM monensin was added to the cultures. Staining of CD4 surface expression was performed. Cells were washed, fixed, permeabilized, and stained for intracellular IL-10 using PE-conjugated specific Abs. One of five independent experiments is shown.
Figure 1.
Figure 1.
Coculture of CD4+CD25+ and CD4+CD25− T cells results in high level IL-10 production. CD4+CD25+ and CD4+CD25− T cells were MACS® sorted from PBMCs of healthy individuals. These cells were either cultured alone or at a 1:1 ratio and activated with platebound anti-CD3 and soluble anti-CD28 (10 μg/ml, respectively). (A) After various time points supernatants were analyzed for cytokine production by ELISA. IL-10 production peaked 48 h after onset of culture and was markedly higher in the coculture of CD4+CD25+ and CD4+CD25− T cells than in the cultures of each of the cell types alone. A representative out of five independent standardized experiments is shown. No elevated levels of INF-α or TGF-β could be measured (data not shown). (B) The different T cell populations were also activated with mature allogeneic DCs (DC/T cell ratio 1:20) compared with anti-CD3 and anti-CD28 (10 μg/ml, respectively). Cytokines were measured 48 h after onset of culture. Results were similar in five independent experiments. (C) For the last 6 h of activation with anti-CD3 and anti-CD28 2 μM monensin was added to the cultures. Staining of CD4 surface expression was performed. Cells were washed, fixed, permeabilized, and stained for intracellular IL-10 using PE-conjugated specific Abs. One of five independent experiments is shown.
Figure 1.
Figure 1.
Coculture of CD4+CD25+ and CD4+CD25− T cells results in high level IL-10 production. CD4+CD25+ and CD4+CD25− T cells were MACS® sorted from PBMCs of healthy individuals. These cells were either cultured alone or at a 1:1 ratio and activated with platebound anti-CD3 and soluble anti-CD28 (10 μg/ml, respectively). (A) After various time points supernatants were analyzed for cytokine production by ELISA. IL-10 production peaked 48 h after onset of culture and was markedly higher in the coculture of CD4+CD25+ and CD4+CD25− T cells than in the cultures of each of the cell types alone. A representative out of five independent standardized experiments is shown. No elevated levels of INF-α or TGF-β could be measured (data not shown). (B) The different T cell populations were also activated with mature allogeneic DCs (DC/T cell ratio 1:20) compared with anti-CD3 and anti-CD28 (10 μg/ml, respectively). Cytokines were measured 48 h after onset of culture. Results were similar in five independent experiments. (C) For the last 6 h of activation with anti-CD3 and anti-CD28 2 μM monensin was added to the cultures. Staining of CD4 surface expression was performed. Cells were washed, fixed, permeabilized, and stained for intracellular IL-10 using PE-conjugated specific Abs. One of five independent experiments is shown.
Figure 2.
Figure 2.
Activated fixed CD4+CD25+ T cells show similar regulatory potential as viable CD4+CD25+ T cells and can induce IL-10 production in CD4+CD25− T cells. (A) CD4+ T cell subpopulations were sorted by MACS® CD4+CD25+ T cells were divided into three fractions. One part was activated with platebound anti-CD3 (10 μg/ml) and soluble anti-CD28 (10 μg/ml) overnight and fixed the next day with paraformaldehyde 2% (activated-fixed). The third part was fixed with paraformaldehyde without activation (resting-fixed) and the second part was left untreated (viable). Each fraction was mixed with syngeneic CD4+CD25− T cells at a 1:1 ratio (105 T cells per 96 well) and stimulated with platebound anti-CD3 (10 μg/ml) and soluble-anti-CD28 (10 μg/ml). Proliferation was determined by 3[H]Tdr incorporation after 5 d. Results are representative of five independent experiments, shown as mean cpm of triplicate cultures. Similar results were observed when T cells were stimulated with mature allogeneic DCs (DC/T cell ratio of 1:20; data not shown) (B) CD4+CD25+ and CD4+CD25− T cells were either cultured alone or CD4+CD25− T cells were mixed at a 1:1 ratio with activated-fixed, resting-fixed or viable CD4+CD25+ T cells. T cells were stimulated with mature allogeneic DCs at the same ratio as in A. In a parallel transwell approach CD4+CD25+ T cells were stimulated with allogeneic DCs (DC/T ratio 1:20) in a transwell chamber, and CD4+CD25− T cells were placed in the well together with allogeneic DCs again at a DC/T ratio of 1:20. IL-10 production was measured by ELISA 48 h after onset of culture. Results were similar in five independent experiments.
Figure 2.
Figure 2.
Activated fixed CD4+CD25+ T cells show similar regulatory potential as viable CD4+CD25+ T cells and can induce IL-10 production in CD4+CD25− T cells. (A) CD4+ T cell subpopulations were sorted by MACS® CD4+CD25+ T cells were divided into three fractions. One part was activated with platebound anti-CD3 (10 μg/ml) and soluble anti-CD28 (10 μg/ml) overnight and fixed the next day with paraformaldehyde 2% (activated-fixed). The third part was fixed with paraformaldehyde without activation (resting-fixed) and the second part was left untreated (viable). Each fraction was mixed with syngeneic CD4+CD25− T cells at a 1:1 ratio (105 T cells per 96 well) and stimulated with platebound anti-CD3 (10 μg/ml) and soluble-anti-CD28 (10 μg/ml). Proliferation was determined by 3[H]Tdr incorporation after 5 d. Results are representative of five independent experiments, shown as mean cpm of triplicate cultures. Similar results were observed when T cells were stimulated with mature allogeneic DCs (DC/T cell ratio of 1:20; data not shown) (B) CD4+CD25+ and CD4+CD25− T cells were either cultured alone or CD4+CD25− T cells were mixed at a 1:1 ratio with activated-fixed, resting-fixed or viable CD4+CD25+ T cells. T cells were stimulated with mature allogeneic DCs at the same ratio as in A. In a parallel transwell approach CD4+CD25+ T cells were stimulated with allogeneic DCs (DC/T ratio 1:20) in a transwell chamber, and CD4+CD25− T cells were placed in the well together with allogeneic DCs again at a DC/T ratio of 1:20. IL-10 production was measured by ELISA 48 h after onset of culture. Results were similar in five independent experiments.
Figure 3.
Figure 3.
CD4+CD25− T cells anergized by CD4+CD25+ T cells suppress proliferation of CD4+ T cells in a IL-10–dependent manner. MACS® sorted CD4+CD25+ and CD4+CD25− T cells were either cultured alone or mixed at a 1:1 ratio (2 × 106 T cells per 24 well) and stimulated with mature allogeneic DCs (DC/T cell ratio 1:20) or immobilized anti-CD3/soluble anti-CD28. After 48 h of culture cells were harvested and one fraction of each population was fixed with paraformaldehyde for 1 h. Viable and fixed cells were cocultured with syngeneic resting CD4+CD25− T cells at a 1:1 ratio (105 T cells per 96 well) and stimulated as before with immobilized anti-CD3/soluble anti-CD28 (bottom panel) or mature allogeneic DCs (top panel) in the presence or absence of 10 μg/ml anti–IL-10 Abs. In a parallel transwell approach the three different T cell populations were placed in a transwell chamber and resting CD4+CD25− T cells were stimulated with DCs (DC/T cell ratio 1:20; top panel) or platebound anti-CD3/soluble anti-CD28 (bottom panel) in the well. Proliferation after 5 d was determined by 3[HT]Tdr incorporation. One out of four independent experiments is shown.
Figure 4.
Figure 4.
(A) Anergized CD4+CD25− T cells predominantly secrete IL-10. CD4+CD25+ and CD4+CD25− T cells were isolated as described and stimulated alone or at a 1:1 ratio with anti-CD3/anti-CD28. 48 h after stimulation supernatant was harvested and analyzed by a cytometric bead array for IL-2, IL-4, IL-5, TNF-α, and INF-γ. Results were similar in five independent experiments. (B) Before mixing CD4+CD25− and CD4+CD25+ T cells at a 1:1 ratio, CD4+CD25+ T cells were labeled with 0.5 μM CFSE for 15 min. Cells were then mixed and stimulated with immobilized anti-CD3/soluble anti-CD28. After 48 h cells were harvested and sorted on a FACSVantage™. The positive and the negative fraction were then cocultured with syngeneic resting CD4+CD25− T cells (105 T cells per 96 well). Proliferation was measured after 5 d by 3[HT]Tdr incorporation. One out of five independent experiments is shown.
Figure 4.
Figure 4.
(A) Anergized CD4+CD25− T cells predominantly secrete IL-10. CD4+CD25+ and CD4+CD25− T cells were isolated as described and stimulated alone or at a 1:1 ratio with anti-CD3/anti-CD28. 48 h after stimulation supernatant was harvested and analyzed by a cytometric bead array for IL-2, IL-4, IL-5, TNF-α, and INF-γ. Results were similar in five independent experiments. (B) Before mixing CD4+CD25− and CD4+CD25+ T cells at a 1:1 ratio, CD4+CD25+ T cells were labeled with 0.5 μM CFSE for 15 min. Cells were then mixed and stimulated with immobilized anti-CD3/soluble anti-CD28. After 48 h cells were harvested and sorted on a FACSVantage™. The positive and the negative fraction were then cocultured with syngeneic resting CD4+CD25− T cells (105 T cells per 96 well). Proliferation was measured after 5 d by 3[HT]Tdr incorporation. One out of five independent experiments is shown.

References

    1. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387–396.
    1. Takahashi, T., Y. Kuniyasu, M. Toda, N. Sakaguchi, M. Itoh, M. Iwata, J. Shimizu, and S. Sakaguchi. 1998. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969–1980.
    1. Thornton, A.M., and E.M. Shevach. 1998. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287–296.
    1. Jonuleit, H., E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, and A.H. Enk. 2001. Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285–1294.
    1. Levings, M.K., R. Sangregorio, and M.G. Roncarolo. 2001. Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295–1302.
    1. Dieckmann, D., H. Plottner, S. Berchtold, T. Berger, and G. Schuler. 2001. Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J. Exp. Med. 193:1303–1310.
    1. Taylor, P.A., R.J. Noelle, and B.R. Blazar. 2001. CD4+ CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193:1311–1318.
    1. Nakamura, K., A. Kitani, and W. Strober. 2001. Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629–644.
    1. Shimizu, J., S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi. 2002. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135–142.
    1. McHugh, R.S., M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, M. Collins, and M.C. Byrne. 2002. CD4+ CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16:311–323.
    1. Papiernik, M., M.L. de Moraes, C. Pontoux, F. Vasseur, and C. Penit. 1998. Regulatory CD4 T cells: expression of IL-2R α chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10:371–378.
    1. Salomon, B., D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:431–440.
    1. Kumanogoh, A., X. Wang, I. Lee, C. Watanabe, M. Kamanaka, W. Shi, K. Yoshida, T. Sato, S. Habu, M. Itoh, N. Sakaguchi, S. Sakaguchi, and H. Kikutani. 2001. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J. Immunol. 166:353–360.
    1. Jooss, K., B. Gjata, O. Danos, H. von Boehmer, and A. Sarukhan. 2001. Regulatory function of in vivo anergized CD4+ T cells. Proc. Natl. Acad. Sci. USA. 98:8738–8743.
    1. Romani, N., D. Reider, M. Heuer, S. Ebner, E. Kampgen, B. Eibl, D. Niederwieser, and G. Schuler. 1996. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J. Immunol. Methods 196:137–151.
    1. Thurner, B., C. Roder, D. Dieckmann, M. Heuer, M. Kruse, A. Glaser, P. Keikavoussi, E. Kampgen, A. Bender, and G. Schuler. 1999. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J. Immunol. Methods 223:1–15.
    1. Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245–252.
    1. Ng, W.F., P.J. Duggan, F. Ponchel, G. Matarese, G. Lombardi, A.D. Edwards, J.D. Isaacs, and R.I. Lechler. 2001. Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood. 98:2736–2744.
    1. Iellem, A., M. Mariani, R. Lang, H. Recalde, P. Panina-Bordignon, F. Sinigaglia, and D. D'Ambrosio. 2001. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J. Exp. Med. 194:847–853.
    1. Yamagiwa, S., J.D. Gray, S. Hashimoto, and D.A. Horwitz. 2001. A role for TGF-β in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J. Immunol. 166:7282–7289.
    1. Stephens, L.A., C. Mottet, D. Mason, and F. Powrie. 2001. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31:1247–1254.
    1. Taams, L.S., J. Smith, M.H. Rustin, M. Salmon, L.W. Poulter, and A.N. Akbar. 2001. Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31:1122–1131.
    1. Moore, K.W., P. Vieira, D.F. Fiorentino, M.L. Trounstine, T.A. Khan, and T.R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science. 248:1230–1234.
    1. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A.H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772–4780.
    1. Romagnoli, P., D. Hudrisier, and J.P. van Meerwijk. 2002. Preferential recognition of self antigens despite normal thymic deletion of CD4+CD25+ regulatory T cells. J. Immunol. 168:1644–1648.
    1. de Waal, M.R., H. Yssel, and J.E. de Vries. 1993. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150:4754–4765.
    1. Schandene, L., C. Alonso-Vega, F. Willems, C. Gerard, A. Delvaux, T. Velu, R. Devos, M. de Boer, and M. Goldman. 1994. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 152:4368–4374.
    1. Bejarano, M.T., M.R. de Waal, J.S. Abrams, M. Bigler, R. Bacchetta, J.E. de Vries, and M.G. Roncarolo. 1992. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int. Immunol. 4:1389–1397.
    1. Thornton, A.M., and E.M. Shevach. 2000. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183–190.
    1. Steinbrink, K., H. Jonuleit, G. Muller, G. Schuler, J. Knop, and A.H. Enk. 1999. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells. Blood. 93:1634–1642.

Source: PubMed

3
Abonnieren